Pharmaceutical administration form for peptides, process for its preparation, and use
US7696149B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 4, 2005 |
| Grant date | Apr 13, 2010 |
| Priority date | — |
| Expiry date | Jan 11, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for preventing aggregation of an LHRH antagonist in a pharmaceutical composition. The method comprises combining the LHRH antagonist in the form of an acetate, gluconate, glucuronate, lactate, citrate, ascorbate, benzoate or phosphate salt and at least one of the acids for forming the salts in free acid form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.